The Valley Desk

ArticleBlood cancer discoveryPublished

Preclinical characterization of the potent and selective MALT1 inhibitor safimaltib in B-cell lymphoma models

14 of 43 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Blood cancer discovery
Published
PubMed ID
43002421
Added to directory
Source checked

Report a correction or request removal